Hu Yi-Bin, Fei Jun, Hu De-Xin, Chen Gen-Jun, Hu Jin-Ping
The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, China.
Department of Orthopaedics, Hangzhou Chest Hospital Affiliated to Zhejiang University Medical College, Hangzhou 310003, Zhejiang, China.
Zhongguo Gu Shang. 2024 Jan 25;37(1):51-6. doi: 10.12200/j.issn.1003-0034.20230279.
To observe the clinical efficacy of lesion removal, bone grafting, fusion, and external fixation in the treatment of late-stage wrist tuberculosis.
From October 2015 to May 2019, 25 patients with late-stage wrist tuberculosis were treated using lesion removal, bone grafting, fusion, and external fixation. Among these patients, there were 14 males and 11 females, aged from 40 to 74 years old, with an average age of (60.72±8.45) years old. The duration of the disease ranged from 5 to 24 months, with an average of (11.52±7.61) months. There were 11 cases of left wrist tuberculosis and 14 cases of right wrist tuberculosis, with 5 cases accompanied by sinus formation. Postoperative regular anti-tuberculosis treatment was continued. Visual analogue score (VAS), inflammatory indicators, Gartland-Werley wrist function score, and upper limb function score were observed before and after treatment.
All 25 patients were followed up for ranging from 12 to 36 months with an average of (19.7±6.3) months. At the latest follow-up, all wounds were healed satisfactorily, and there was no recurrence of tuberculosis or infection. VAS at one week before operation and three months after operation were (5.16±1.14) score and (1.68±0.80) score respectively. One week before operation and three months after operation, erythrocyte sedimentation rate (ESR) was (44.20±20.56) mm·h and (14.44±1.14) mm·h, and C-reactive protein (CRP) was (12.37±7.95) mg·L and (4.3±3.37) mg·L. The differences in all three data sets were statistically significant (<0.01). According to Gartland-Werley wrist function scoring, the scores at one week before operation and one year after operation were (21.32±3.44) and (14.96±1.37) respectively, showed a statistically significant difference (<0.01). According to the upper limb function score (disabilities of the arm, shoulder, and hand, DASH), the score was (70.52±7.95) at one week before operation and(28.84±2.30) at one year after operation. The difference was statistically significant (<0.01). At the latest follow-up, no patient had a recurrence of tuberculosis.
The short-term clinical efficacy of treating wrist tuberculosis with lesion removal, bone grafting, fusion, and external fixation is satisfactory.
观察病灶清除、植骨、融合及外固定治疗晚期腕关节结核的临床疗效。
2015年10月至2019年5月,采用病灶清除、植骨、融合及外固定治疗25例晚期腕关节结核患者。其中男性14例,女性11例,年龄40~74岁,平均(60.72±8.45)岁。病程5~24个月,平均(11.52±7.61)个月。左腕结核11例,右腕结核14例,5例伴有窦道形成。术后继续规律抗结核治疗。观察治疗前后视觉模拟评分(VAS)、炎症指标、Gartland-Werley腕关节功能评分及上肢功能评分。
25例患者均获随访,随访时间12~36个月,平均(19.7±6.3)个月。末次随访时,所有伤口均愈合良好,无结核复发及感染。术前1周及术后3个月VAS评分分别为(5.16±1.14)分和(1.68±0.80)分。术前1周及术后3个月红细胞沉降率(ESR)分别为(44.20±20.56)mm·h和(14.44±1.14)mm·h,C反应蛋白(CRP)分别为(12.37±7.95)mg/L和(4.3±3.37)mg/L。三组数据差异均有统计学意义(<0.01)。根据Gartland-Werley腕关节功能评分,术前1周及术后1年评分分别为(21.32±3.44)分和(14.96±1.37)分,差异有统计学意义(<0.01)。根据上肢功能评分(上肢、肩部和手部功能障碍,DASH),术前1周评分为(70.52±7.95)分,术后1年评分为(28.84±2.30)分,差异有统计学意义(<0.01)。末次随访时,无患者结核复发。
病灶清除、植骨、融合及外固定治疗腕关节结核的短期临床疗效满意。